Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409

Clinical trial NCT02255656 · COMPLETED

Trial details

NCT number: NCT02255656
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2015-01-07
Primary completion: 2020-07-15
Enrollment: 1062

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.